- Home
- HIND vs SNSE Comparison
HIND vs SNSE Comparison
Compare HIND & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIND
- SNSE
- Stock Information
- Founded
- HIND N/A
- SNSE 2005
- Country
- HIND United States
- SNSE United States
- Employees
- HIND N/A
- SNSE N/A
- Industry
- HIND
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- HIND
- SNSE Health Care
- Exchange
- HIND Nasdaq
- SNSE Nasdaq
- Market Cap
- HIND 10.3M
- SNSE 10.5M
- IPO Year
- HIND 2016
- SNSE 2021
- Fundamental
- Price
- HIND $7.95
- SNSE $8.32
- Analyst Decision
- HIND
- SNSE Strong Buy
- Analyst Count
- HIND 0
- SNSE 4
- Target Price
- HIND N/A
- SNSE $72.50
- AVG Volume (30 Days)
- HIND N/A
- SNSE 16.5K
- Earning Date
- HIND N/A
- SNSE 08-05-2025
- Dividend Yield
- HIND N/A
- SNSE N/A
- EPS Growth
- HIND N/A
- SNSE N/A
- EPS
- HIND N/A
- SNSE N/A
- Revenue
- HIND N/A
- SNSE N/A
- Revenue This Year
- HIND N/A
- SNSE N/A
- Revenue Next Year
- HIND N/A
- SNSE N/A
- P/E Ratio
- HIND N/A
- SNSE N/A
- Revenue Growth
- HIND N/A
- SNSE N/A
- 52 Week Low
- HIND N/A
- SNSE $5.00
- 52 Week High
- HIND N/A
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- HIND N/A
- SNSE 52.54
- Support Level
- HIND N/A
- SNSE $7.79
- Resistance Level
- HIND N/A
- SNSE $9.08
- Average True Range (ATR)
- HIND 0.00
- SNSE 0.63
- MACD
- HIND 0.00
- SNSE 0.06
- Stochastic Oscillator
- HIND 0.00
- SNSE 59.39
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).